Livzon Pharmaceutical Group, Inc. (LVZPF)
3.799
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Livzon Pharmaceutical Group Net Income (Quarterly) : 58.31M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.31M |
| March 31, 2026 | 104.56M |
| December 31, 2025 | 39.60M |
| September 30, 2025 | 80.90M |
| June 30, 2025 | 103.35M |
| March 31, 2025 | 110.44M |
| December 31, 2024 | 49.88M |
| September 30, 2024 | 82.48M |
| June 30, 2024 | 88.18M |
| March 31, 2024 | 99.62M |
| December 31, 2023 | 37.81M |
| September 30, 2023 | 62.13M |
| June 30, 2023 | 79.80M |
| March 31, 2023 | 89.72M |
| December 31, 2022 | 55.54M |
| September 30, 2022 | 64.62M |
| June 30, 2022 | 76.57M |
| March 31, 2022 | 96.26M |
| December 31, 2021 | 53.11M |
| September 30, 2021 | 66.89M |
| June 30, 2021 | 90.13M |
| March 31, 2021 | 92.26M |
| December 31, 2020 | 46.01M |
| September 30, 2020 | 71.65M |
| June 30, 2020 | 122.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 66.29M |
| December 31, 2019 | 40.69M |
| September 30, 2019 | 48.51M |
| June 30, 2019 | 57.71M |
| March 31, 2019 | 65.33M |
| December 31, 2018 | 22.16M |
| September 30, 2018 | 51.83M |
| June 30, 2018 | 48.43M |
| March 31, 2018 | 57.68M |
| December 31, 2017 | 27.48M |
| September 30, 2017 | 562.99M |
| June 30, 2017 | 36.66M |
| March 31, 2017 | 43.39M |
| December 31, 2016 | 25.92M |
| September 30, 2016 | 33.81M |
| June 30, 2016 | 27.48M |
| March 31, 2016 | 37.90M |
| December 31, 2015 | 18.45M |
| September 30, 2015 | 26.83M |
| June 30, 2015 | 27.31M |
| March 31, 2015 | 32.56M |
| December 31, 2014 | 16.60M |
| September 30, 2014 | 22.78M |
| June 30, 2014 | 26.02M |
| March 31, 2014 | 24.42M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 312.73M |
| Total Expenses (Quarterly) | 260.53M |
| EPS Diluted (Quarterly) | 0.0588 |
| Enterprise Value | 2.971B |
| Gross Profit Margin (Quarterly) | 52.93% |
| Profit Margin (Quarterly) | 18.65% |
| Earnings Yield | 7.12% |
| Operating Earnings Yield | 9.23% |
| Normalized Earnings Yield | 7.026 |